Carsten Schneider

Percutaneous, transendocardial injection of bone marrow-derived mononuclear cells in heart failure patients following acute ST-elevation myocardial infarction: ALSTER-Stem Cell trial

• Heeger C-H,
• Jaquet K,
• Thiele H,
• Zulkarnaen Y,
• Cuneo A,
• Haller D,
• Kivelitz D,
• Schmidt T,
• Krause K,
• Metzner A,
• Schneider C,
• Kuck K-H,
• Bergmann M

EuroIntervention 2012;8:732-742

Published in Volume 8 Number 6, October 2012

Release patterns of cardiac markers after TAVI as compared to surgical aortic valve replacement

• Bleiziffer S,
• Piazza N,
• Schneider C,
• Opitz A,
• Hettich I,
• Mazzitelli D,
• Lange R

Published in Volume 7 Supplement M, May 2011

Percutaneous, intra-myocardial injection of unselected bone marrow-derived mononuclear cells via NOGA-XP significantly improves ejection fraction in post-infarct patients: ALSTER STEM CELL

• Bergmann M,
• Jaquet K,
• Schneider C,
• Cuneo A,
• Krause K,
• Haller H,
• Kivelitz D,
• Kuck K-H

Published in Volume 7 Supplement M, May 2011